Search

Your search keyword '"Wuchter, Patrick"' showing total 593 results

Search Constraints

Start Over You searched for: Author "Wuchter, Patrick" Remove constraint Author: "Wuchter, Patrick"
593 results on '"Wuchter, Patrick"'

Search Results

2. Mobilization and Collection of HSC

4. Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial

5. Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignancies

7. AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas

9. One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients

11. Platelet storage and functional integrity

14. International Forum on Blood Donation in Individuals with Current, Past or Germline Predisposition to Malignancy: Summary

15. International Forum on Blood Donation in Individuals with Current, Past or Germline Predisposition to Malignancy: Responses

19. High-risk additional chromosomal abnormalities at low blast counts herald death by CML

25. Significant improvement of bone marrow-derived MSC expansion from MDS patients by defined xeno-free medium

26. SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays

30. Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012

36. Flow Cytometric Characterization of Hematopoietic Stem and Progenitor Cell Subpopulations in Autologous Peripheral Blood Stem Cell Preparations after Cryopreservation

41. Standardization of Good Manufacturing Practice–compliant production of bone marrow–derived human mesenchymal stromal cells for immunotherapeutic applications

42. Inhibition of Lysyl Oxidases Synergizes with 5-Azacytidine to Restore Erythropoiesis in Myeloid Neoplasms

43. ASXL1 Mutations Are Associated with a Response to the Combination of Alvocidib and 5-Azacytidine in Higher-Risk Myelodysplastic Syndromes

44. Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML

49. Human Mesenchymal Stromal Cells Do Not Cause Radioprotection of Head-and-Neck Squamous Cell Carcinoma

Catalog

Books, media, physical & digital resources